Structured Summary
Abstract
Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
Synonyms
13 entry terms
- Antifibrinolysin
- Antifibrinolysins
- Antifibrinolytic
- Antifibrinolytic Agent
- Antifibrinolytics
- Agent, Antifibrinolytic
- Agents, Antifibrinolytic
- Antiplasmin
- Antiplasmins
- Plasmin Inhibitor
- Plasmin Inhibitors
- Inhibitor, Plasmin
- Inhibitors, Plasmin
MeSH Record
Aspects Covered
22 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
66
MeSH Hierarchy
Tree Numbers
MeSH Record
NLM Classification
QV 195
AMA Style
References
- National Library of Medicine. Antifibrinolytic Agents. Medical Subject Headings (MeSH). 2026. Unique ID D000933. http://id.nlm.nih.gov/mesh/2026/D000933
- Antifibrinolytic Agents. In: Wikipedia. https://en.wikipedia.org/wiki/Antifibrinolytic
- Antifibrinolytic Agents. In: Wikidata. https://www.wikidata.org/wiki/Q575222